Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
about
Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell linesThe antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factorsICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation.Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survivalMechanisms and novel approaches in overriding tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting.The cancer stem cell hypothesis: a guide to potential molecular targets.Do we need more drugs for chronic myeloid leukemia?Forkhead transcription factor FOXO1 inhibits nuclear factor-κB in gastric cancer.Bcl6 gene-silencing facilitates PMA-induced megakaryocyte differentiation in K562 cells.Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells.
P2860
Q33914049-FF90B8F2-B390-4025-A056-19DD93F2890DQ34806728-D0AF7B7F-8A12-471F-9214-B63FC7BDA3DEQ35101189-3ED2D842-8FAA-4E09-8C17-25362DF1368BQ35776432-29F3F9C0-13CB-4321-BEF7-6AA6CA6CF959Q37988569-8E7C4A54-098A-4058-95B4-34B934E36699Q38187388-6FB4C8FF-BA2A-4EE1-B18F-1C5F5DA62412Q38254181-22D519C7-5A8A-41FB-880B-04AE4E5EB218Q38289033-454C1827-860A-4D7A-B9F7-9932EACFD937Q39011214-97E33875-C16B-452C-A793-9B541F80718EQ47155635-577C4ACA-C30D-41B3-87D4-C14CCB2A9D17Q53095313-BC244E29-E4E0-40F6-B747-C5A6A5DC29F7
P2860
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@en
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@nl
type
label
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@en
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@nl
prefLabel
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@en
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@nl
P2860
P921
P356
P1476
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks.
@en
P2093
Francesca Pellicano
P2860
P304
P356
10.1084/JEM.20112087
P407
P577
2011-10-01T00:00:00Z
2011-10-24T00:00:00Z